* Pulmonx Corp LUNG.OQ LUNG.O is expected to show a rise
in
quarterly revenue when it reports results on October 30 for the
period ending September 30 2024
* The Redwood City California-based company is expected to
report
a 14.8% increase in revenue to $20.288 million from $17.67
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Pulmonx Corp is for a
loss
of 45 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$14.00, above its last closing price of $6.21.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.42 -0.43 -0.35 Beat 17.7
Mar. 31 2024 -0.45 -0.46 -0.36 Beat 22
Jan. 1 0001 -0.38 -0.41 -0.36 Beat 11.6
Jan. 1 0001 -0.42 -0.43 -0.39 Beat 8.8
Jun. -0.44 -0.44 -0.43 Beat 1.6
30 2023
Mar. 31 2023 -0.44 -0.44 -0.42 Beat 4.5
Jan. 1 0001 -0.43 -0.42 -0.38 Beat 8.7
Sep. 30 2022 -0.40 -0.40 -0.38 Beat 4.2
This summary was machine generated October 29 at 03:06 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)